Dorman Products, Inc. Reports Fourth Quarter and Fiscal 2019 Results, Issues Fiscal 2020 Guidance
Fourth Quarter 2019 net sales of $239.6 million, down 8% compared to $260.3 million in the prior year.Diluted earnings per […]
GW Pharmaceuticals to Present at the Cowen 40th Annual Healthcare Conference
LONDON and CARLSBAD, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the […]
ProQR to Present at Cowen and Company 40th Annual Health Care Conference
LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 24, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company […]
ORAL ARGUMENT HAS BEEN SET IN DIGITAL ALLY’S APPEAL IN THE AXON ENTERPRISES LITIGATION
The Federal Circuit Sets Oral Argument for April 6, 2020Lenexa, KS, Feb. 24, 2020 (GLOBE NEWSWIRE) — Digital Ally, Inc. […]
Autolus Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 3
LONDON, Feb. 24, 2020 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell [...]
Paratek Announces License Grant to Almirall for SEYSARA® (sarecycline) for Greater China Region
BOSTON, Feb. 24, 2020 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development […]
Nuance Announces the General Availability of Ambient Clinical Intelligence
BURLINGTON, Mass., Feb. 24, 2020 (GLOBE NEWSWIRE) — Nuance Communications, Inc (NASDAQ: NUAN) today announced the general availability and accelerated […]
G1 Therapeutics to Present at Investor Conferences in March 2020
RESEARCH TRIANGLE PARK, N.C., Feb. 24, 2020 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today […]
Altair names Gilma Saravia new Chief People Officer
TROY, Mich., Feb. 24, 2020 (GLOBE NEWSWIRE) — Altair, (Nasdaq: ALTR) a global technology company providing solutions in product development, […]
Interpace Announces Extension of LabCorp Agreement
ThyGeNEXT and ThyraMIR Collaboration Extended for Another Two YearsPARSIPPANY, NJ, Feb. 24, 2020 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (NASDAQ: […]
